rxstat › Drug prices › Cobicistat / Elvitegravir / Emtricitabine / Tenofovir Disoproxil

Cobicistat / Elvitegravir / Emtricitabine / Tenofovir Disoproxil (Stribild) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Nov 16, 2026

Cobicistat / Elvitegravir / Emtricitabine / Tenofovir Disoproxil 150 mg / 150 mg / 200 mg / 300 mg tablet costs about $45.52 to $48.02 per tablet on public drug plan price lists across 3 provinces, before the pharmacy's dispensing fee.

Cobicistat / Elvitegravir / Emtricitabine / Tenofovir Disoproxil has no current shortage reported in Canada. No active reports are on file.

Price by province

Strength and formABSKONNBNS
150 mg / 150 mg / 200 mg / 300 mg Tabletper tablet$46.39not covered$45.52$48.02$47.22–
Plan coverageNot coveredSpecial approvalCoveredSpecial approvalNot covered

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 1 product
  • Stribild 150 mg / 150 mg / 200 mg / 300 mg Tablet · GIL
    DIN 02397137 · $46.39/tablet · Not covered
Saskatchewan: 1 product
  • Stribild 150 mg / 150 mg / 200 mg / 300 mg Tablet · GSI
    DIN 02397137 · $45.52/tablet · Special approval
Ontario: 1 product
  • Stribild 150 mg / 150 mg / 200 mg / 300 mg Tablet · Gilead Sciences Canada, Inc.
    DIN 02397137 · $48.02/tablet · Covered
New Brunswick: 1 product
  • Stribild 150 mg / 150 mg / 200 mg / 300 mg Tablet · GIL
    DIN 02397137 · $47.22/tablet · Special approval
Nova Scotia: 1 product
  • Stribild 150 mg / 150 mg / 200 mg / 300 mg Tablet · GIL
    DIN 02397137 · no listed price · Not covered

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

No shortage or discontinuation reports have been filed with Health Canada for Cobicistat / Elvitegravir / Emtricitabine / Tenofovir Disoproxil. rxstat watches those reports through the day; sign up below to hear if that changes.

Common questions

How much does Cobicistat / Elvitegravir / Emtricitabine / Tenofovir Disoproxil cost in Canada?

Cobicistat / Elvitegravir / Emtricitabine / Tenofovir Disoproxil 150 mg / 150 mg / 200 mg / 300 mg tablet costs about $45.52 to $48.02 per tablet on public drug plan price lists across 3 provinces, before the pharmacy's dispensing fee.

Is Cobicistat / Elvitegravir / Emtricitabine / Tenofovir Disoproxil covered by provincial drug plans?

On the public plans' own lists: Alberta: not covered; Saskatchewan: special approval; Ontario: covered; New Brunswick: special approval; Nova Scotia: not covered. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (direct acting antivirals)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.